Versant Ventures related stories
All articles and analysis
- KYTHERA Biopharmaceuticals Closes $37.4M
KYTHERA Biopharmaceuticals Inc., a company developing products in aesthetic medicine, has closed on $37.4 million in Series D financing. KYTHERA’s investors include Versant Ventures, ARCH Venture Partners, Prospect Venture Partners, JAFCO, Partner Funds management, INVUS Financial Advisors, BBT Capital Management, and Altitude Life Science Ventures. Also joining the syndicate were Foley Ventures and Latham and Watkins. KYTHERA has now raised more than $108 million to date.
- Intuity Medical Seals $76M Series D
Intuity Medical Inc., a developer of glucose monitoring technologies for managing diabetes, has closed a second tranche of its Series D financing, bringing the round’s total to $76 million. Accuitive Medical Ventures joined as a new investor. The firm is also backed by Investor Growth Capital, Thomas McNerney and Partners, Venrock, Versant Ventures and U.S. Venture Partners. Intuity Medical is based in Sunnyvale, Calif.
- Bristol-Myers Squibb Buys VC-backed Amira Pharma
Bristol-Myers Squibb Co. will acquire privately held Amira Pharmaceuticals in an all-cash transaction worth up to $475 million. The deal includes $325 million upfront, with potential additional milestone payments totaling $150 million, the companies announced Thursday. Amira Pharmaceuticals was backed by investors including Novo A/S, Avalon Ventures, Prospect Venture Partners and Versant Ventures.
- Benvenue Medical Wraps Up $35.5M in Series C
Benvenue Medical Inc., a Mountain View, Calif.-based developer of minimally invasive solutions for spine repair, has closed a $35.5 million Series C round. Domain Associates and Technology Partners co-led the round, which included support from existing shareholders Versant Ventures and DeNovo Ventures. Nimesh Shah, principal at Domain Associates, and Roger Quy, general partner of Technology Partners, will join the board as a result of the round.
Health Care Dialing Up Mobile AppsSmart docs are using smart phones in their patient care and more app developers and VCs are joining the conversation